Myriad Genetics
MYGN
#7319
Rank
NZ$0.95 B
Marketcap
NZ$9.97
Share price
-1.44%
Change (1 day)
-13.12%
Change (1 year)

EPS for Myriad Genetics (MYGN)

EPS in 2026 (TTM): NZ-$2.39

According to Myriad Genetics's latest financial reports the company's current EPS (TTM) is NZ-$2.48. In 2025 the company made an earnings per share (EPS) of NZ-$7.19 a decrease over its 2024 EPS that were of NZ-$2.57.

EPS history for Myriad Genetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$2.39-66.76%
2025NZ-$7.19179.43%
2024NZ-$2.57-55.94%
2023NZ-$5.84130.22%
2022NZ-$2.54275.68%
2021NZ-$0.68-87.99%
2020NZ-$5.62755.56%
2019NZ-$0.66-194.74%
2018NZ$0.69-79.89%
2017NZ$3.45112.36%
2016NZ$1.62-35.97%
2015NZ$2.54-7.33%
2014NZ$2.74-37.24%
2013NZ$4.3659.33%
2012NZ$2.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
NZ$4.93-298.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
NZ-$9.71 291.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ-$0.16-93.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ-$92.90 3,642.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
NZ$69.65-2,905.88%๐Ÿ‡บ๐Ÿ‡ธ USA